ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00938951
Recruitment Status : Completed
First Posted : July 14, 2009
Last Update Posted : February 9, 2012
Sponsor:
Information provided by (Responsible Party):
Alcon Research

July 13, 2009
July 14, 2009
February 9, 2012
June 2009
July 2009   (Final data collection date for primary outcome measure)
Effectiveness of eye drop basd on athlete's opinion/experience during a one hour practice session [ Time Frame: 60 minutes post-dosing with test article ]
Percent change from baseline of time of visual clarity following acute instillation of test article at a single visit. [ Time Frame: Baseliine and 5 minutes post instillation ]
Complete list of historical versions of study NCT00938951 on ClinicalTrials.gov Archive Site
Not Provided
Adverse event occurence [ Time Frame: Post instillation of test article ]
Not Provided
Not Provided
 
Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.
Not Provided
The primary objective of this study is to compare visual degradation in a stressed (forced stare) environment in patients before and after acute administration of Systane Ultra.
Not Provided
Interventional
Not Applicable
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
  • Dry Eye Symptoms
  • Visual Performance
Other: Systane® Ultra
Polyethylene Glycol 400 0.4% / Propylene Glycol 0.3%
Experimental: Systane® Ultra
Systane® Ultra
Intervention: Other: Systane® Ultra
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
16
20
Not Provided
July 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Player/ Coach must answer "Yes" to the survey eligibility question.
  • Player/Coach must voluntarily agree to participate in survey

Exclusion Criteria:

Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Not Provided
United States
 
NCT00938951
SMA-09-22
No
Not Provided
Not Provided
Alcon Research
Alcon Research
Not Provided
Not Provided
Alcon Research
February 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP